Access to medicines through health systems in low- and middle-income countries.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Works by Leopold, Christine
Results: 15
1
2
How to Price and to Reimburse Publicly Funded Medicines in Latin America? Lessons Learned from Europe.
- Published in:
- Journal of Law, Medicine & Ethics, 2023, v. 51, p. 76, doi. 10.1017/jme.2023.114
- By:
- Publication type:
- Article
3
The Complex Cancer Care Coverage Environment — What is the Role of Legislation? A Case Study from Massachusetts.
- Published in:
- Journal of Law, Medicine & Ethics, 2020, v. 48, n. 3, p. 538, doi. 10.1177/1073110520958879
- By:
- Publication type:
- Article
4
Defining Value of Cancer Therapeutics-A Health System Perspective.
- Published in:
- 2018
- By:
- Publication type:
- journal article
5
PP24 Creating A Comprehensive Open-Access Health Technology Assessment (HTA) Policy Research Database Through Automated Data Extraction From HTA Reports.
- Published in:
- International Journal of Technology Assessment in Health Care, 2025, v. 40, p. S64, doi. 10.1017/S0266462324001971
- By:
- Publication type:
- Article
6
Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries.
- Published in:
- Bulletin of the World Health Organization, 2014, v. 92, n. 9, p. 630, doi. 10.2471/BLT.13.129114
- By:
- Publication type:
- Article
7
Managed Entry Agreements for High-Cost, One-Off Potentially Curative Therapies: A Framework and Calculation Tool to Determine Their Suitability: Framework and Calculation Tool to Determine the Suitability of MEAs: M.H.E. Callenbach et al.
- Published in:
- PharmacoEconomics, 2025, v. 43, n. 1, p. 53, doi. 10.1007/s40273-024-01433-4
- By:
- Publication type:
- Article
8
Impact of External Price Referencing on Medicine Prices - A Price Comparison Among 14 European Countries.
- Published in:
- Southern Med Review, 2012, v. 5, n. 2, p. 34
- By:
- Publication type:
- Article
9
Pharmaceutical policies in European countries in response to the global financial crisis.
- Published in:
- Southern Med Review, 2011, v. 4, n. 2, p. 22, doi. 10.5655/smr.v4i2.1004
- By:
- Publication type:
- Article
10
Drivers of expenditure on primary care prescription drugs in 10 high-income countries with universal health coverage.
- Published in:
- 2017
- By:
- Publication type:
- journal article
11
Total and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plans.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 2, p. 449, doi. 10.1007/s10549-018-4819-6
- By:
- Publication type:
- Article
12
Erratum to: Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer.
- Published in:
- 2016
- By:
- Publication type:
- Erratum
13
Author's response to 'letter to the editor: lower vitamin D status may explain racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer'.
- Published in:
- 2016
- By:
- Publication type:
- Letter
14
Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 158, n. 2, p. 333, doi. 10.1007/s10549-016-3875-z
- By:
- Publication type:
- Article
15
Integrating public preferences into national reimbursement decisions: a descriptive comparison of approaches in Belgium and New Zealand.
- Published in:
- 2020
- By:
- Publication type:
- journal article